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O B J E C T I V E S We sought to quantify the mortality rates associated with absent and low positive
(CAC 1 to 10) coronary artery calcium (CAC).
B A C KG ROUND There is increasing interest in the absence of CAC as a “negative” cardiovascular
risk factor. However, published event rates for individuals with no CAC vary, likely owing to differences
in baseline risk, follow-up period, and outcome ascertainment. The prognostic signiﬁcance of low CAC
(CAC 1 to 10) is not well described.
METHOD S Annualized all-cause mortality rates were assessed in 44,052 consecutive asymptomatic
patients referred for CAC testing. Mean follow-up of the cohort was 5.6 2.6 years (range 1 to 13 years).
R E S U L T S A total of 19,898 patients (45%) had no CAC on screening electron beam tomography,
whereas 5,388 (12%) had low levels of CAC (CAC 1 to 10), and 18,766 (43%) had CAC 10. There were
104 deaths in those with no CAC (0.52%), 58 deaths in those with CAC 1 to 10 (1.06%), and 739 deaths
in those with CAC 10 (3.96%). Annualized all-cause mortality rates for CAC  0, CAC 1 to 10, and CAC
10 were 0.87, 1.92, and 7.48 deaths/1,000 person-years, respectively. The hazard ratio (HR) for all-cause
mortality among CAC 1 to 10 versus CAC  0 after adjustment for traditional risk factors was 1.99 (95%
conﬁdence interval [CI]: 1.44 to 2.75). Smoking (HR: 3.97, 95% CI: 2.75 to 5.41) and diabetes mellitus (HR:
3.36, 95% CI: 2.09 to 5.41) were associated with few events observed in CAC  0 group.
CONC L U S I O N S In appropriately selected asymptomatic patients, the absence of CAC predicts
excellent survival with 10-year event rates of approximately 1%. A ﬁnding of 0 CAC might be used as a
rationale to emphasize lifestyle therapies rather than pharmacotherapy and to forgo repeated imaging
studies. Individuals with low CAC score (CAC 1 to 10) are at increased risk above individuals with a 0
score and could be considered a distinct risk group by physicians and investigators. (J Am Coll Cardiol
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693he presence of calcium in coronary arteries
is pathogenomonic of atherosclerosis, as con-
firmed by histopathology and intravascular
ultrasound studies (1–4). Coronary artery cal-
ium (CAC), detected and quantified with cardiac
omputed tomography, represents a reliable linear
natomic estimate of total plaque burden (5) and is
epresented clinically as a “calcium score.” Nearly all
rospective studies have found moderate-to-high
AC to be an independent and incremental pre-
ictor of future cardiovascular events over conven-
ional risk factors and the Framingham Risk Score
6–15). Therefore current guidelines recommend
easurement of CAC for further risk stratification
f intermediate risk individuals, in whom treatment
ith long-term aspirin and statin therapy is most
ncertain (5,16).
There is increasing interest in the absence of
AC (a calcium score of 0) as a “negative”
ardiovascular risk factor (17,18). Absence of
AC might reliably exclude obstructive coronary
isease in asymptomatic and selected symptomatic
ndividuals and seems to be associated with a low
ardiovascular event rate, suggesting that less ag-
ressive pharmacotherapy might be indicated in this
opulation (19). However, published event rates for
ndividuals with 0 CAC vary, likely owing to
ifferences in baseline risk, follow-up period, as well
s outcome ascertainment and verification (18). The
haracteristics of the few individuals with 0 CAC
ho subsequently develop cardiovascular events
ave not been well-described.
Less is known about the prognosis of a low
ositive CAC score (CAC 1 to 10), because most
tudies are underpowered to report this as a
istinct group. Some studies have reported in-
reased and variable noncalcified soft coronary
laque in patients with low CAC (20). Budoff
t al. (13) recently reported a 2.5-fold increased
isk with CAC 1 to 10 as compared with 0 CAC,
lthough this difference was not statistically
ignificant after adjusting for conventional risk
actors.
To further elucidate the prognosis of absent (0)
nd low positive (CAC 1 to 10) CAC, we studied
large combined cohort of 44,052 asymptomatic
ndividuals referred for screening electron beam
omography (EBT). We sought to describe the
ll-cause mortality rate in individuals with 0 CAC
s well as the all-cause mortality rate in individuals
ith low CAC (CAC 1 to 10) in relation to those
ith no CAC. tE T H O D S
he study cohort consisted of 44,052 consecutive
symptomatic individuals free of known coronary
eart disease (CHD) referred for EBT for the assess-
ent of subclinical atherosclerosis. Patients were de-
ermined to be free of CHD on the basis of patient
istory and prior work-up conducted by the referring
hysician. The dataset for this study represents the
ombination of data from 3 centers, each representing
everal sites geographically dispersed throughout the
.S., for which similar methods have been defined for
ata accumulation. The combined population was
redominantly white and middle-aged.
Study participants were referred by their primary
hysicians on the basis of established cardiovascular
isk factors for atherosclerosis and, as such, do not
epresent a random sample of the general population.
ll screened individuals provided informed consent to
ndergo EBT and for the use of their blinded data for
pidemiologic research. The general study received
pproval from the Human Investigations Committee,
nd separate Committee approval was obtained for
he patient interviews, collection of baseline
nd follow-up data, and corroboration of the
ccurrence of death.
isk factor data collection. All study partic-
pants were given a questionnaire for the
ollection of demographic and clinical
haracteristics as well as baseline cardio-
ascular risk factors. Cigarette smoking
as considered present if a subject was a smoker at
he time of scanning. Dyslipidemia was considered
o be present for any individual reporting a history
f high total cholesterol, high low-density lipopro-
ein cholesterol, low high-density lipoprotein cho-
esterol, and/or high triglycerides or current use of
ipid-lowering therapy. Study subjects were consid-
red to have diabetes if they reported using oral
nti-diabetes medications or insulin. Hypertension
as defined as a self-reported history of high blood
ressure or use of antihypertensive medication.
amily history of CHD was determined by asking
atients whether any member of their immediate
amily (parents or siblings) had a history of fatal or
onfatal myocardial infarction and/or coronary re-
ascularization. Body mass index was calculated for
ndividuals who self-reported a height and weight.
ndividuals with body mass index 30 kg/m2 were
onsidered obese.
BT screening protocol. All subjects underwent EBT
n either a C-100 or C-150 Ultrafast computed
A B B
A N D
CAC
CHD
EBT
tomogomography scanner (GE-Imatron, South SanR E V I A T I O N S
A C R O N YM S
coronary artery calcium
coronary heart disease
electron beamFran-
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694isco, California). With a tomographic slice thickness
f 3 mm, a total of approximately 40 sections were
btained beginning at the level of the carina and
roceeding caudally to the level of the diaphragm.
mages were obtained with a 100-ms/slice scanning
ime, with image acquisition electrocardiographically
riggered at 60% to 80% of the R-R interval.
A calcified lesion was defined as 3 contiguous
ixels with a peak attenuation of at least 130
ounsfield units. Each lesion was then scored with
he method developed by Agatston et al. (21).
ollow-up and mortality ascertainment. Patients were
ollowed for a mean of 5.6  2.6 years (range 1 to
3 years). Follow-up was completed in 100% of the
atients. The primary end point for the study
ohort was mortality from any cause. Ascertainment
f mortality was conducted by individuals blinded
o baseline historical data and EBT results. The
ccurrence of death was verified with the Social
ecurity Death Index.
tatistical methods. The baseline characteristics of
he study population are presented by pre-specified
AC group (0, 1 to 10, 10) and in aggregate for
he entire study population. Age is presented as a
ontinuous measure  SD, and other risk variables
re expressed as proportional frequencies. Age was
ompared across increasing CAC groups with anal-
sis of variance techniques, and proportional fre-
uencies of other risk variables were compared
cross increasing CAC groups with chi-square
nalysis. A p value 0.05 was considered statisti-
ally significant.
Annualized all-cause mortality rates were esti-
ated by dividing the number of deaths by the
umber of person-years at risk. Mortality rates are
rst expressed for each CAC group and then
tratified according to pre-specified age group
45, 45 to 64,65 years) as well as by presence of
ndividual categorical risk factors.
Table 1. Baseline Characteristics of Study Population
Variable
Total
(n  44,052)
CAC 
(n  19,898;
Age (yrs) 54  10 50  10
Sex (male) 54% 52%
Current smoker 14% 12%
HTN 34% 26%
DM 5% 3%
Hyperlipidemia 30% 24%
Family history of heart attack 37% 35%
p value for trend across coronary artery calcium (CAC) [score] categories.
DM  diabetes mellitus; HTN  hypertension.In addition, survival analysis was conducted with
ndividual subject time-to all-cause mortality data.
urves representing the cumulative probability of
urvival were generated with Kaplan-Meier esti-
ates. To evaluate the effect of CAC group on
ll-cause mortality, hazard ratios (HRs) and 95%
onfidence intervals (CIs) were calculated with the
ox proportional hazards regression model with
AC  0 as the reference group. Three hierar-
hical models were constructed: Model 1: unad-
usted; Model 2: adjusted for age and sex; and
odel 3: adjusted for age, sex, hypertension,
yslipidemia, diabetes mellitus, smoking, and fam-
ly history of CHD.
Finally, the relationship of individual risk factors
ith all-cause mortality was tested by adjusting for
ll risk factors simultaneously in a multivariable Cox
egression model. The risk imparted by these fac-
ors was modeled both in patients with 0 CAC and
n the entire study population.
All statistical analyses were performed with Stata
ersion 8 (STATA Corp., College Station, Texas).
E S U L T S
linical characteristics of study cohort. The final
tudy population consisted of 44,052 asymptomatic
ndividuals free of known cardiovascular disease at
aseline. Average age for the study cohort was 54
0 years, with slightly over one-half being male
54%). A total of 19,898 patients (45%) had no
AC on screening EBT, whereas 5,388 (12%) had
ow levels of CAC (CAC 1 to 10), and 18,766
43%) had CAC 10 (Table 1). Overall, with
ncreasing CAC scores, the population was signif-
cantly more likely to be male and older, with
ncreased prevalence of smoking, hypertension, di-
betes, and dyslipidemia as well as higher likelihood
f family history of heart disease (all p  0.0001).
)
CAC 1 to 10
(n  5,388; 12%)
CAC >10
(n  18,766; 43%) p Value
52  10 59  10 0.0001
57% 55% 0.0001
11% 17% 0.0001
32% 42% 0.0001
5% 9% 0.0001
27% 36% 0.0001
36% 40% 0.00010
45%
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695ll-cause mortality rates and CAC. Overall, there were
01 deaths (2.05%) in the total study population
ver a mean follow-up of 5.6  2.6 years (range 1
o 13 years). There were 104 deaths in those with
o CAC (0.52%), 58 deaths in those with CAC 1
o 10 (1.06%), and 739 deaths in those with CAC
10 (3.96%). The annualized mortality rate in-
reased from 0.87 deaths/1,000 person-years (95%
I: 0.72 to 1.05) to 1.89 deaths/1,000 person-years
95% CI: 1.46 to 2.45) and to 7.48/1,000 person-
ears (95% CI: 6.95 to 8.04) for those with CAC
, CAC 1 to 10, and CAC10, respectively (Table
). Cumulative survival for the 3 groups was 99.5%,
8.9%, and 96.1% (Fig. 1). Survival curves accord-
ng to CAC scores in women and men are shown in
igures 2 and 3, respectively.
Table 3 provides unadjusted and multivariable ad-
usted HRs for all-cause mortality in patients with low
AC (CAC 1 to 10) and CAC 10 in relation to
hose with no CAC. In unadjusted analysis, CAC 1 to
0 was associated with greater than two-fold increased
isk of death from any cause (HR: 2.19, 95% CI: 1.57
o 2.99) as compared with those with a CAC score of
. After adjustment for age and sex (Model 2), the
R was slightly attenuated to 2.02 but remained
ighly significant (95% CI: 1.47 to 2.79, p 0.0001).
he increased risk in patients with CAC 1 to 10
ersisted after adjustment for age, sex, hypertension,
moking, diabetes, dyslipidemia, and family history of
HD (Model 3: HR: 1.99, 95% CI: 1.45 to 2.75).
atients with CAC 10 had in excess of an 8-fold
ncreased unadjusted risk of death compared with
ndividuals with a CAC score of 0 (HR: 8.48, 95% CI:
.82 to 10.29); this was attenuated to a 5-fold and
-fold increase in Models 2 and 3, respectively. In
ddition, for comparison purposes the HRs for all-
ause mortality among those with CAC scores of 101
o 400 and 400 as compared with CAC  0 in
odel 3 were 5.56 (95% CI: 4.27 to 7.21) and 9.65
95% CI: 7.46 to 12.5), respectively.
isk factors and all-cause mortality in individuals with
o CAC. Increasing age remained a risk factor for
ll-cause mortality in patients with no CAC. Pa-
Table 2. All-Cause Mortality Rates by CAC Scores in Overall Pop
No. of Patients No. of Events
CAC  0 19,898 (45%) 104 (0.52%)
CAC 1 to 10 5,388 (12%) 58 (1.06%)
CAC 10 18,766 (43%) 739 (3.96%)
Total 44,052 (100%) 901 (2.05%)
CAC  coronary artery calcium; CI  conﬁdence interval.ients age 45 years and 45 to 64 years had a lowortality rate (0.67 and 0.77 deaths/1,000 person-
ears, respectively), whereas patients 65 and older
ere at increased risk of death (2.22 deaths/1,000
erson-years). Presence of hypertension, diabetes,
nd dyslipidemia as well as smoking status also
emained risk factors for all-cause mortality in
atients with no coronary calcium. The highest
ortality rate among individuals with CAC score
f 0 was observed in those with diabetes (3.72
eaths/1,000 person-years vs. 0.81 deaths/1,000
erson-years in those without diabetes) and smok-
rs (3.31 deaths/1,000 person-years vs. 0.67 deaths/
,000 person-years for nonsmokers). Despite no
oronary calcium, study subjects with a family
istory of CHD had a slightly increased all-cause
ortality compared with those without such a
amily history (Table 4).
After adjusting for all risk factors simultaneously
n a multivariable model, age, smoking, diabetes
ellitus, and family history of heart disease re-
ained significant predictors of all-cause mortality
n patients with no CAC. These same 4 risk factors
ere significant predictors of all-cause mortality in
Figure 1. Kaplan-Meier Survival Curve According to CAC Scores
(Total Population)
Kaplan-Meier survival curve according to coronary artery calcium (C
scores (total population) demonstrating a low mortality rate among
with CAC  0 as well as higher event rate with presence of low to
tion
Rate/1,000 Person-Yrs at Risk 95% CI for Rate
0.87 0.72–1.05
1.92 1.48–2.48
7.48 6.95–8.04
3.62 3.39–3.89AC)
those
highulaCAC scores.
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696he overall cohort, with similar point estimates of
isk. Smoking (HR: 3.97, 95% CI: 2.75 to 5.41)
nd diabetes mellitus (HR: 3.36, 95% CI: 2.09 to
.41) in particular were associated with the highest
ncreases in risk (Table 5).
I S C U S S I O N
n this combined cohort of 44,052 asymptomatic
iddle-age patients free of known coronary artery
isease, a CAC score of 0 was associated with
xcellent survival, with all-cause mortality rates of
.87/1,000 person-years (1% 10-year risk or
0.1%/year). Conventional cardiovascular risk fac-
ors, particularly smoking and diabetes mellitus, are
aplan-Meier Survival Curve According to CAC Scores (Women)
ier survival curve according to coronary artery calcium (CAC)
men) demonstrating a low mortality rate among those with
s well as higher event rate with presence of low to high CAC
aplan-Meier Survival Curve According to CAC Scores (Men)
ier survival curve according to coronary artery calcium (CAC)
n) demonstrating a low mortality rate among those with CAC  0“
igher event rate with presence of low to high CAC scores.ssociated with a higher relative risk of mortality in
atients with no CAC, although absolute event
ates remain low. Individuals with low CAC scores
CAC 1 to 10) had a nearly 2-fold increased
ortality compared with those with no CAC de-
pite risk factor adjustment, suggesting that patients
ith low CAC represent a distinct risk group.
owever, mortality rates in individuals with low
AC scores remained low (5% 10-year risk,
0.5%/year), and this group remained a low overall
isk with traditional Framingham risk stratification.
This cohort represents the largest follow-up
ataset yet studied for the occurrence of all-cause
eath after CAC scanning. The size of this study
opulation, with over 25,000 patients with CAC
cores between 0 and 10 and over 900 all-cause
eaths, lends considerable statistical power to the
valuation of the long-term prognosis of both 0
AC and the smaller low-CAC group. The end
oint, all-cause mortality, frees this investigation of
he bias imparted by the ascertainment and verifi-
ation of cardiovascular events (22,23).
mplications for no CAC. The very low mortality
ates observed for individuals without CAC in
his study are similar to event rates observed in
ther studies of middle-aged asymptomatic pa-
ients. Arad et al. (11) reported an event rate
quivalent to 1/1,000 person-years, Taylor et al.
12) demonstrated an event rate equivalent to
.6/1,000 person-years, whereas Raggi et al. (8)
emonstrated an event rate equivalent to 1.1
vents/1,000 person-years. Shaw et al. (24) ob-
erved 39 events during a mean follow-up of 5
ears in a large series of 5,067 patients with no
AC, equivalent to a crude annualized event rate
f 1.5 events/1,000 person-years.
LaMonte et al. (25) observed 15 events during a
ean follow-up of 3.5 years among 2,692 individ-
als with no CAC, equivalent to 1.6 events/1,000
erson-years. Recently Detrano et al. (14), publish-
ng from the MESA (Multiethnic Study of Ath-
rosclerosis) cohort, reported 8 major cardiac events
ver 3.7 years among 3,409 patients without CAC,
quivalent to an event rate of 0.6/1,000 person-
ears. In 1 of the largest studies previously pub-
ished, Budoff et al. (13) reported a cumulative
2-year survival of 99.4% amongst 11,046 patients
ith no CAC, resulting in an event rate of approx-
mately 0.6/1,000 person-years.
The present study adds to the growing published
ata supporting no CAC as an important “negative
isk factor” for major cardiovascular outcomes inFigure 2. K
Kaplan-Me
scores (wo
CAC  0 aFigure 3. K
Kaplan-Me
scores (measymptomatic intermediate risk patients.” In addi-
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697ion to a very low overall event rate in middle-aged
atients, CAC score of 0 has been shown to
iscriminate lower risk groups in the elderly (15).
Individuals with no CAC are also extremely
nlikely to have obstructive coronary disease. In a
ooled analysis of 10,355 symptomatic patients who
nderwent coronary angiography (1,941 with no
AC), the presence of any CAC had a sensitivity of
8% and a negative predictive value of 93% for
etection of clinically significant coronary stenosis
19). These data are consistent with direct patho-
ogic comparisons (26).
No CAC is also associated with a very low risk of
ardiac ischemia. In 9 studies examining 4,870
atients referred for perfusion stress testing (1,225
ith no CAC), just 6% had evidence of ischemia
19). Finally, in 3 studies totaling 431 patients
resenting to the emergency room with chest pain,
egative cardiac biomarkers, and equivocal electro-
ardiography findings (183 with no CAC), a CAC
core of 0 had a 99% predictive value for ruling out
cute coronary syndrome (19).
However, attention must be paid to the under-
ying risk of a population when considering the
alue of a CAC score of 0; the few studies that
eported higher event rates in patients with no
AC considered higher-risk sub-groups. For ex-
mple, Schenker et al. (27) reported a 16% inci-
ence of inducible ischemia in patients with no
AC undergoing positron emission tomography/
omputed tomography. All patients in this study
ere symptomatic, including 34% with either dys-
nea or classic exertional angina. Recently, Henne-
an et al. (28) noted a 70% prevalence of obstruc-
ive coronary disease as seen by computed
omography angiography in patients without CAC
resenting to the emergency room with high sus-
icion of acute coronary syndrome. In accordance
ith Bayes theorem and current clinical guidelines,
he value of a CAC score of 0 as a “negative risk
actor” lies in the intermediate-risk primary preven-
ion population rather than high-risk populations.
In the appropriately selected non–high-risk pa-
ient, the absence of CAC could potentially be used
s a rationale to emphasize lifestyle therapy, scale
ack on costly preventive pharmacotherapy, and
efrain from frequent cardiac imaging and testing.
iven the low 1% 10-year risk in this population, a
rug that produces a 30% relative risk reduction
ould have to be given to over 300 patients for 10
ears to prevent 1 death (number needed to treat,
pproximately 333 for 10 years). In addition, recent
ata suggest that repeat CAC imaging could beelayed in this population for perhaps 5 years.
opal et al. (29) showed that in 710 physician-
eferred patients with no CAC at baseline, less than
ne-half developed CAC, whereas just 4% devel-
ped CAC scores 50 at 5 years’ follow-up. In the
ESA cohort, only 16% of individuals with no
AC developed some degree of CAC at median
ollow-up of 41 months (30).
However, it is important to keep in mind that
ven in the absence of CAC, relatively more events
ccur among those with higher risk especially in
iabetic patients and smokers, who are at increased
isk for in-situ thrombosis and coronary vasospasm
hat can be independent of coronary atherosclerosis.
his scenario is analogous to the elevation of
ardiac enzymes in the face of a “clean” coronary
Table 3. All-Cause Mortality (HR, 95% CI) for All-Cause Mortalit
(CAC 1 to 10) and CAC >10 Compared With CAC  0
CAC  0 CAC 1 to 10
Model 1 1 (ref) 2.19 (1.57–2.99)
Model 2 1 (ref) 2.02 (1.47–2.79)
Model 3 1 (ref) 1.99 (1.45–2.75)
Model 1: unadjusted; Model 2: age-, sex-adjusted; Model 3: age-, sex-, hyperten
mellitus–, hyperlipidemia-, and family history of coronary heart disease–adjuste
CAC  coronary artery calcium; CI  conﬁdence interval; HR  hazard ratio.
Table 4. All-Cause Mortality Rates by Absence and Presence of
Among Those With CAC  0
Rate/1,000 Person-Yrs at Risk
Age, yrs
45 0.67
45–64 0.77
65 2.22
Sex
Female 0.91
Male 0.84
Hypertension
No 0.75
Yes 1.69
Smoking
No 0.67
Yes 3.31
Diabetes mellitus
No 0.81
Yes 3.72
Hyperlipidemia
No 0.70
Yes 1.72
Family history of CHD
No 0.63
Yes 1.59y With Low CAC
CAC >10
8.38 (6.82–102.9)
4.96 (4.02–6.11)
4.08 (3.30–5.04)
sion-, smoking-, diabetes
d.CHD Risk Factors
95% CI for Rate
0.45–1.01
0.59–1.00
1.49–3.32
0.69–1.20
1.63–1.10
0.61–0.95
1.14–2.50
0.53–0.84
2.31–4.74
0.66–0.99
1.94–7.16
0.56–0.89
1.23–2.40
0.48–0.82
1.20–2.10CHD  coronary heart disease; CI  conﬁdence interval.
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698ngiogram. However, apart from this reason, an-
ther potential mechanism could be that those with
isk factors such as diabetes and smoking even in
he presence of CAC are more likely to develop
ncident CAC during follow-up, as shown by Kron-
al et al. (30), and thus might explain the increased
isk of outcomes in longer-term follow-up. Further
tudies assessing whether this increased risk of
evelopment of new CAC in these low-risk indi-
iduals will further shed light on the higher risk
een with risk factors such as diabetes mellitus and
moking even in the absence of CAC at baseline.
The present study is the first to describe risk
actors for the few events that occur in patients with
o CAC. Contrary to a prior report (31), diabetes
nd smoking are associated with the limited mor-
ality observed in individuals with no CAC. This
ight be due to mechanisms separate from the
enesis of atherosclerotic plaque, including im-
aired endothelial function, prothrombotic state,
nd increased vasospasm. Although absolute mor-
ality rates remain low (3 to 4 deaths/1,000 person-
ears, equivalent to 3% to 4% 10-year risk), risk in
hese patients warrants further study, and these
atients should continue close follow-up and phar-
acotherapy according to present guidelines.
mplications for low CAC score (CAC 1 to 10). To our
nowledge, this is the first study to confirm a robust
ncreased risk in patients with low positive CAC.
udoff et al. (13) recently reported an unadjusted
elative risk of 2.5 with CAC 1 to 10, although this
ifference was not statistically significant after ad-
usting for cardiovascular risk factors.
Recent computed tomography angiography data
uggest a mechanism for the observed increased
isk. Cheng et al. (20) scanned 554 low- to
ntermediate-risk outpatients and expressed the
revalence of noncalcified coronary artery plaque
of Risk Factors With All-Cause Mortality in Overall Population
 0
Overall
HR (95% CI)
CAC  0
HR (95% CI)
1.67 (1.46–1.90) 1.63 (1.38–1.93)
1.15 (0.84–1.57) 0.91 (0.62–1.33)
1.32 (0.91–1.89) 1.04 (0.64–1.68)
3.97 (2.75–5.41) 3.63 (2.28–5.75)
3.36 (2.09–5.41) 2.51 (1.24–5.05)
0.95 (0.66–1.37) 1.24 (0.78–1.96)
1.57 (1.11–2.20) 1.53 (1.00–2.34)
the multivariate Cox regression models simultaneously.
3.NCAP) as a function of CAC. Compared with datients with no CAC, individuals with low CAC
CAC 1 to 10) had marked increased rate of NCAP
65% vs. 7%), including NCAP causing 50%
uminal obstruction (9% vs. 1%). The authors hy-
othesize a threshold effect, consistent with prior
istopathology data, whereby a significant burden
f NCAP might need to be present before intimal
ydroxyapatite accumulates.
Clinicians and future investigators should, on the
asis of the results of the present study, refrain from
erging no CAC and low CAC into a single group.
or some patients, including younger individuals
nd women, a low absolute CAC score might
ndeed represent a high percentile. Dedicated stud-
es, stratified by age and sex, are needed to better
efine the risk in patients with low CAC.
tudy limitations. There are a few limitations to this
tudy. First, all patients were referred for CAC
creening and therefore do not represent a random
ample of the population. In general, patients re-
erred for CAC scans might be at higher risk
ompared with age-matched patients from the
eneral population. If this were the case in the
resent study, the finding of excellent survival
mongst patients with no CAC could be considered
ven more striking. Comparison with published
ata reveals that our observed CAC frequency and
istribution is similar to that seen in 2 large
opulation-based epidemiologic studies—MESA
nd CARDIA (Coronary Artery Risk Develop-
ent in Young Adults) (32).
A second potential weakness is the self-reporting
f risk factors. Data gathered by self report is
imited by patient recall and thus subject to recall
ias. However, patient reporting of hypertension
as been validated as an acceptable way to assess
isk factor data (33). Although the lack of a con-
inuous risk variable might decrease the precision of
oint estimates of risk, the use of categorical risk
actor data has been validated as an approach to
linical risk stratification (34).
Our models do not include the cause of death,
nd as such, our models might be based on mortal-
ty unrelated to atherosclerotic disease. However,
ll-cause mortality is an appropriate end point to
ollow, because when one accounts for both cardiac
nd systemic forms of the disease, nearly three-
ourths of all deaths have been related to athero-
clerosis (23). Furthermore, this end point is unaf-
ected by the reporting and misclassification bias
otentially introduced by a physician’s filing of aTable 5. Relationship
and Those With CAC
Age/10 yrs
Male
Hypertension
Smoking
Diabetes mellitus
Hyperlipidemia
Fam history of CHD
All risk factors adjusted ineath report (22).
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699Finally, more detailed conclusions in our study
re not possible due to the lack of cardiovascular-
pecific mortality data. Although CHD remains the
ost common killer in industrialized countries, it is
ot possible to ascertain the proportion of deaths
hat are cardiovascular in origin. Although CAC is
resumed to influence mortality mainly via cardio-
ascular mechanisms, other risk factors such as
moking and diabetes contribute to all-cause mor-
ality via additional noncardiovascular mechanisms
i.e., lung disease and kidney dysfunction). There-
ore it is not possible in this study to conclude that
moking and diabetes cause excess cardiovascular
eaths in the no CAC population.
O N C L U S I O N S
e conclude that, in appropriately selected asymp-
omatic patients, absence of CAC predicts excellentology. Circulation 2006;114:1761–91.
Francis Heart Stud
diol 2005;46:158–6% (0.1%/year). On the basis of this finding, in
onjunction with published reports supporting in-
remental improved risk assessment when CAC is
dded to conventional risk factors, a finding of no
AC might allow shifting of these patients into
ower risk groups. As such, physicians might con-
ider emphasizing appropriate lifestyle therapy, us-
ng less pharmacotherapy, and ordering less costly
ardiac imaging studies in these patients. Patients
ho smoke and have diabetes, however, should be
reated according to existing guidelines. Individuals
ith low positive CAC (CAC 1 to 10) are at
ncreased risk compared with those with a CAC
core of 0 and should be considered a distinct albeit
ow-risk group by physicians and investigators.
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